Cited 0 time in
카바페넴분해효소 생성 장내세균속균종(CPE)이 획득된 내과계 중환자실 환자의 생존 영향 요인
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 최지은 | - |
| dc.contributor.author | 전미양 | - |
| dc.date.accessioned | 2022-12-26T13:17:44Z | - |
| dc.date.available | 2022-12-26T13:17:44Z | - |
| dc.date.issued | 2020-11 | - |
| dc.identifier.issn | 2383-6415 | - |
| dc.identifier.issn | 2383-6423 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/7311 | - |
| dc.description.abstract | Purpose: Carbapenemase-producing Enterobacteriaceae (CPE) are associated with considerable mortality. This study was aimed to identify survival factors among medical care unit patients with CPE. Methods: We conducted a retrospective cohort; data were collected from September 2017 to June 2019 through electronic medical records. The data collected were general characteristics, disease-related characteristics, severity-related characteristics, and treatment-related characteristics. Data were analyzed based on frequency, mean, standard deviation, Chi-square test, Fisher’s exact test, t-test, Pearson’s correlation coefficient, and Cox proportional hazard model using SPSS/WIN 21.0 program. Results: Seventy-seven patients were included (59 survivors and 18 deceased) in the study. Univariate analysis identified factors for survival associated with acquired CPE as age (t=-1.56, p=.037), simplified acute physiology 3 (SAPS3) score of admission date (t=-2.85, p=.006), Glasgow coma scale (GCS) of CPE acquisition date (t=2.38, p=.020), artery catheter at CPE acquisition date (χ2=4.58, p=.032), vasoconstrictor agents use at CPE acquisition date (χ2=6.81, p=.009), platelet at CPE acquisition date (t=2.27, p=.025), lymphocyte at CPE acquisition date (t=2.01, p=.048), calcium at CPE acquisition date (t=2.68, p=.009), albumin at CPE acquisition date (t=2.29, p=.025), and creatinine at CPE acquisition date (t=2.24, p=.028). Multivariate Cox proportional hazard model showed that GCS at CPE acquisition date (HR=1.14, 95% CI=1.05-1.22), lymphocyte at CPE acquisition date (HR=1.05, 95% CI=1.00-1.10), and creatinine at CPE acquisition date (HR=1.25, 95% CI=1.04-1.49) were independent survival factors among medical intensive care unit patients with CPE. Conclusion: Based on the study results, it is necessary to develop nursing interventions that can aid in the management of patients with CPE and identify their effects. | - |
| dc.format.extent | 11 | - |
| dc.language | 한국어 | - |
| dc.language.iso | KOR | - |
| dc.publisher | 기초간호학회 | - |
| dc.title | 카바페넴분해효소 생성 장내세균속균종(CPE)이 획득된 내과계 중환자실 환자의 생존 영향 요인 | - |
| dc.title.alternative | Survival Factors among Medical Intensive Care Unit Patients with Carbapenemas-Producing Enterobacteriaceae | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.7586/jkbns.2020.22.4.249 | - |
| dc.identifier.scopusid | 2-s2.0-85209804041 | - |
| dc.identifier.bibliographicCitation | Journal of korean biological nursing science, v.22, no.4, pp 249 - 259 | - |
| dc.citation.title | Journal of korean biological nursing science | - |
| dc.citation.volume | 22 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 249 | - |
| dc.citation.endPage | 259 | - |
| dc.identifier.kciid | ART002652053 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Carbapenemase | - |
| dc.subject.keywordAuthor | Enterobacteriaceae | - |
| dc.subject.keywordAuthor | Intensive care units | - |
| dc.subject.keywordAuthor | Survival | - |
| dc.subject.keywordAuthor | 카바페넴분해효소 | - |
| dc.subject.keywordAuthor | 장내세균속균종 | - |
| dc.subject.keywordAuthor | 중환자실 | - |
| dc.subject.keywordAuthor | 생존 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
